Skip to content

Polaryx Therapeutics, Inc. PLYX Deferred Tax Assets, Gross

Deferred Tax Assets, Gross at other companies

Bank of America logo
Bank of AmericaBAC
$24.18B-5.9%
MSCI logo
MSCIMSCI
$191.15M+1.9%
Arthur J. Gallagher logo
Arthur J. GallagherAJG
$2.73B+48.6%
American International Group logo
American International GroupAIG
$5.88B-9.6%
PNC Financial Services logo
PNC Financial ServicesPNC
$3.52B-25.0%
Phillips 66 logo
Phillips 66PSX
$1.25B-2.7%

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$115.64M

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsGross.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's deferred tax assets, gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's deferred tax assets, gross?
Polaryx Therapeutics, Inc. (PLYX) reported deferred tax assets, gross of $6.64M in Q4 2025.